spacer
spacer

PDBsum entry 1a8k

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase/hydrolase inhibitor PDB id
1a8k

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
99 a.a. *
Ligands
0Q4 ×2
Waters ×477
* Residue conservation analysis
PDB id:
1a8k
Name: Hydrolase/hydrolase inhibitor
Title: Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved ca-p2 substrate: interactions with frequently occurring glutamic acid residue at p2' position of substrates
Structure: HIV protease. Chain: a, b, d, e. Engineered: yes. Mutation: yes
Source: Human immunodeficiency virus 1. Organism_taxid: 11676. Expressed in: escherichia coli. Expression_system_taxid: 562
Biol. unit: Homo-Dimer (from PDB file)
Resolution:
2.00Å     R-factor:   0.174     R-free:   0.319
Authors: I.T.Weber,J.Wu,J.Adomat,R.W.Harrison,A.R.Kimmel,E.M.Wondrak,J.M.Louis
Key ref: I.T.Weber et al. (1997). Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates. Eur J Biochem, 249, 523-530. PubMed id: 9370363
Date:
27-Mar-98     Release date:   13-Jan-99    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P03367  (POL_HV1BR) -  Gag-Pol polyprotein from Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI)
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1447 a.a.
99 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 3 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class 1: E.C.2.7.7.-  - ?????
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 2: E.C.2.7.7.49  - RNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
+ diphosphate
   Enzyme class 3: E.C.2.7.7.7  - DNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: DNA(n) + a 2'-deoxyribonucleoside 5'-triphosphate = DNA(n+1) + diphosphate
DNA(n)
+ 2'-deoxyribonucleoside 5'-triphosphate
= DNA(n+1)
+ diphosphate
   Enzyme class 4: E.C.3.1.-.-
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 5: E.C.3.1.13.2  - exoribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Exonucleolytic cleavage to 5'-phosphomonoester oligonucleotides in both 5'- to 3'- and 3'- to 5'-directions.
   Enzyme class 6: E.C.3.1.26.13  - retroviral ribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 7: E.C.3.4.23.16  - HIV-1 retropepsin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Specific for a P1 residue that is hydrophobic, and P1' variable, but often Pro.
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
Eur J Biochem 249:523-530 (1997)
PubMed id: 9370363  
 
 
Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates.
I.T.Weber, J.Wu, J.Adomat, R.W.Harrison, A.R.Kimmel, E.M.Wondrak, J.M.Louis.
 
  ABSTRACT  
 
Human immunodeficiency virus type 1 (HIV-1) protease hydrolysis of the Gag CA-p2 cleavage site is crucial for virion maturation and is optimal at acidic pH. To understand the processing of the CA-p2 site, we have determined the structure of HIV-1 protease complexed with an analog of the CA-p2 site, the reduced peptide inhibitor Arg-Val-Leu-r-Phe-Glu-Ala-Ahx-NH2 [r denotes the reduced peptide bond and Ahx 2-aminohexanoic acid (norleucine), respectively]. The crystal structure was refined to an R-factor of 0.17 at 0.21-nm resolution. The crystals have nearly the same lattice as related complexes in P2(1)2(1)2(1) which have twofold disordered inhibitor, but are in space group P2(1). and the asymmetric unit contains two dimers of HIV-1 protease related by 180 degrees rotation. An approximate non-crystallographic symmetry has replaced the exact crystal symmetry resulting in well-ordered inhibitor structure. Each protease dimer binds one ordered inhibitor molecule, but in opposite orientations. The interactions of the inhibitor with the two dimers are very similar for the central P2 Val to P2' Glu residues, but show more variation for the distal P3 Arg and P4' Ahx residues. Importantly, the carboxylate oxygens of Glu at P2' in the inhibitor are within hydrogen-bonding distance of a carboxylate oxygen of Asp30 of the protease suggesting that the two side chains share a proton. This interaction suggests that the enzyme-substrate complex is additionally stabilized at lower pH. The importance of this interaction is emphasized by the absence of polymorphisms of Asp30 in the protease and variants of P2' Glu in the critical CA-p2 cleavage site.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
19899162 R.Ishima, Q.Gong, Y.Tie, I.T.Weber, and J.M.Louis (2010).
Highly conserved glycine 86 and arginine 87 residues contribute differently to the structure and activity of the mature HIV-1 protease.
  Proteins, 78, 1015-1025.
PDB codes: 3jvw 3jvy 3jw2
17729291 M.D.Altman, E.A.Nalivaika, M.Prabu-Jeyabalan, C.A.Schiffer, and B.Tidor (2008).
Computational design and experimental study of tighter binding peptides to an inactivated mutant of HIV-1 protease.
  Proteins, 70, 678-694.
PDB codes: 2nxd 2nxl 2nxm
18481899 N.Kaushik-Basu, A.Basu, and D.Harris (2008).
Peptide inhibition of HIV-1: current status and future potential.
  BioDrugs, 22, 161-175.  
18052235 A.Y.Kovalevsky, A.A.Chumanevich, F.Liu, J.M.Louis, and I.T.Weber (2007).
Caught in the Act: the 1.5 A resolution crystal structures of the HIV-1 protease and the I54V mutant reveal a tetrahedral reaction intermediate.
  Biochemistry, 46, 14854-14864.
PDB codes: 3b7v 3b80
16537628 M.Prabu-Jeyabalan, E.A.Nalivaika, K.Romano, and C.A.Schiffer (2006).
Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate.
  J Virol, 80, 3607-3616.
PDB codes: 2fns 2fnt
15659370 N.Morellet, S.Druillennec, C.Lenoir, S.Bouaziz, and B.P.Roques (2005).
Helical structure determined by NMR of the HIV-1 (345-392)Gag sequence, surrounding p2: implications for particle assembly and RNA packaging.
  Protein Sci, 14, 375-386.
PDB code: 1u57
16218957 Y.Tie, P.I.Boross, Y.F.Wang, L.Gaddis, F.Liu, X.Chen, J.Tozser, R.W.Harrison, and I.T.Weber (2005).
Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 angstroms resolution crystal structures of HIV-1 protease mutants with substrate analogs.
  FEBS J, 272, 5265-5277.
PDB codes: 2aoc 2aod 2aoe 2aof 2aog 2aoh 2aoi 2aoj
15102858 J.Kádas, I.T.Weber, P.Bagossi, G.Miklóssy, P.Boross, S.Oroszlan, and J.Tözsér (2004).
Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease.
  J Biol Chem, 279, 27148-27157.  
15507631 M.Prabu-Jeyabalan, E.A.Nalivaika, N.M.King, and C.A.Schiffer (2004).
Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease.
  J Virol, 78, 12446-12454.
PDB codes: 1tsq 1tsu
14690411 J.C.Clemente, R.Hemrajani, L.E.Blum, M.M.Goodenow, and B.M.Dunn (2003).
Secondary mutations M36I and A71V in the human immunodeficiency virus type 1 protease can provide an advantage for the emergence of the primary mutation D30N.
  Biochemistry, 42, 15029-15035.  
12502847 M.Prabu-Jeyabalan, E.A.Nalivaika, N.M.King, and C.A.Schiffer (2003).
Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy.
  J Virol, 77, 1306-1315.
PDB codes: 1mt7 1mt8 1mt9 1mtb 1n49
12012342 B.Mahalingam, P.Boross, Y.F.Wang, J.M.Louis, C.C.Fischer, J.Tozser, R.W.Harrison, and I.T.Weber (2002).
Combining mutations in HIV-1 protease to understand mechanisms of resistance.
  Proteins, 48, 107-116.
PDB codes: 1k1t 1k1u 1k2b 1k2c
12005435 M.Prabu-Jeyabalan, E.Nalivaika, and C.A.Schiffer (2002).
Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes.
  Structure, 10, 369-381.
PDB codes: 1kj4 1kj7 1kjf 1kjg 1kjh
11340661 B.Mahalingam, J.M.Louis, J.Hung, R.W.Harrison, and I.T.Weber (2001).
Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes.
  Proteins, 43, 455-464.
PDB codes: 1fej 1ff0 1fff 1ffi 1fg6 1fg8 1fgc
10429209 B.Mahalingam, J.M.Louis, C.C.Reed, J.M.Adomat, J.Krouse, Y.F.Wang, R.W.Harrison, and I.T.Weber (1999).
Structural and kinetic analysis of drug resistant mutants of HIV-1 protease.
  Eur J Biochem, 263, 238-245.
PDB codes: 1daz 1dw6 1ebk
10491141 P.Boross, P.Bagossi, T.D.Copeland, S.Oroszlan, J.M.Louis, and J.Tözsér (1999).
Effect of substrate residues on the P2' preference of retroviral proteinases.
  Eur J Biochem, 264, 921-929.  
10508781 R.Ishima, D.I.Freedberg, Y.X.Wang, J.M.Louis, and D.A.Torchia (1999).
Flap opening and dimer-interface flexibility in the free and inhibitor-bound HIV protease, and their implications for function.
  Structure, 7, 1047-1055.  
9521772 J.Wu, J.M.Adomat, T.W.Ridky, J.M.Louis, J.Leis, R.W.Harrison, and I.T.Weber (1998).
Structural basis for specificity of retroviral proteases.
  Biochemistry, 37, 4518-4526.
PDB codes: 1a94 1bai
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer